Causaly Brings Scientific Research to Microsoft Copilot
Causaly's AI platform has integrated with Microsoft Copilot to provide enterprise scientists and knowledge workers with direct access to scientifically grounded research.
This integration allows users to turn evidence into decision-ready intelligence, making it easier for teams to make informed decisions in biopharma. Causaly's platform is powered by a high-precision biomedical knowledge graph and the world's scientific literature, enabling specialized AI agents to automate scientific workflows and accelerate drug discovery and development.
The collaboration between Causaly and Microsoft builds on their previous announcement at Microsoft Build 2026 in June. The integration of Causaly's Agentic Research with Microsoft Discovery's enterprise scientific platform provides a single workflow for teams to access evidence-grounded decision artifacts that can be reviewed and considered by scientific committees.
Causaly is available on the Microsoft Marketplace, and users can invoke its services from within Copilot or through @mentioning it in conversations. The platform's answers are based on prior science, reason over biological mechanisms, and synthesize evidence, providing transparent and accountable insights for decision-making.